Gerard Gallagher is an Executive Editor for Healio, a medical news platform. With a focus on infectious diseases and pediatric practice, Gerard covers a wide range of topics including vaccine updates, COVID-19 testing, public health warnings, and advancements in the field of infectious diseases.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Gerard Gallagher’s coverage primarily focuses on healthcare and pharmaceuticals, with a strong emphasis on infectious diseases, public health, medical research, and vaccines. His articles often cite data and provide expert commentary. To effectively reach out to Gerard Gallagher, consider providing insights or data-backed analysis related to developments in the field of infectious diseases or public health. Experts who can offer valuable perspectives on vaccine development or healthcare preparedness for pandemics would likely be of interest to him.
When reaching out to Gerard Gallagher with pitches for potential stories or expert commentary, it's important to ensure that the content aligns closely with his areas of focus within the healthcare sector. Additionally, given his lack of specified geographic focus but broad international themes covered in healthcare and pharmaceutical fields, he may appreciate insights from global experts as well as those focusing specifically on the US context when relevant.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Gerard Gallagher, Carol L. DiBerardino
LIMA, Peru — Healio is on site for the International AIDS Society's HIV Research for Prevention Conference, which will take place from Oct. 6 to 10.
LIMA, Peru — Positive data continue to roll in for lenacapavir, the long-acting injectable that looks like a game-changer for HIV prevention.
By: Gerard Gallagher, Carol L. DiBerardino
Lima, PERU — Choice, long-lasting protection and HIV prevention in women were three major themes of this week's HIV Research for Prevention conference.
By: Carol L. DiBerardino, Gerard Gallagher
LIMA, Peru — In a finding described as “reassuring,” researchers detected no interaction between the long-acting HIV prevention drug cabotegravir and hormonal contraceptives among women enrolled in a large trial.
By: Carol L. DiBerardino, Gerard Gallagher
LOS ANGELES — Healio is on-site again for IDWeek, which is being held at the Los Angeles Convention Center from Oct. 16-19.
By: Carol L. DiBerardino, Gerard Gallagher
LOS ANGELES — A computer prompt recommending appropriate antibiotic use based on a patient's level of risk for a resistant infection cut the use of
By: Gerard Gallagher, Stephen I. Feller
Video Player is loading. Play Video Play Mute Current Time Duration Loaded
By: Gerard Gallagher, Carol L. DiBerardino
There was a “marked decrease” in COVID-19 vaccine uptake among nursing home personnel last season, according to researchers, who attributed the decline to cost and the end of the CMS's COVID-19 vaccine requirement in mid-2023.
By: Gerard Gallagher, Carol L. DiBerardino
LOS ANGELES —In this video from IDWeek, Vani Vannappagari , MBBS, PhD, MPH, global head of epidemiology and real-world evidence at ViiV
By: Carol L. DiBerardino, Gerard Gallagher
I initially became hooked on ID when I was a medical student rounding on ID service and was evaluating a person with pneumonia who had just expectorated purulent sputum.
(833) 317-6278 
